Cardiology

Sermorelin

Q: What does the research say about Sermorelin?

The scientific consensus on Sermorelin is unknown. No claims extracted for this topic Based on 0 analyzed claims.

Literature on sermorelin, a GHRH(1-29) analog used in growth hormone deficiency diagnostics and research settings.

Unknown pathwayAlso known as: Sermorelin, GHRH 1-29, growth hormone releasing factor 1-29

Claims analyzed

What does the research say about Sermorelin?

Unknown pathwayBased on 0 claims ( agreements, contradictions)

No claims extracted for this topic

New research on Sermorelin

C-reactive protein, cardiovascular risk, and renal disease in a remote Australian Aboriginal community

Clinical Science — McDonald S — Jan 2004

Albumin-to-Globulin Ratio as an Independent Predictor of Mortality in Chronic Heart Failure

Biomarkers in Medicine — Niedziela J — Jun 2018

Clinical relevance of HRR (hemoglobin to RDW) and RAR (RDW to albumin) in pericarditis

Biomarkers in Medicine — Eyiol H — Feb 2025

Development and validation of a risk prediction model for hypoproteinemia after adult cardiac valve surgery: implications for clinical care

Evidence brief: Sermorelin

Sermorelin (also known as Sermorelin, GHRH 1-29, growth hormone releasing factor 1-29). Literature on sermorelin, a GHRH(1-29) analog used in growth hormone deficiency diagnostics and research settings.

As of 2026-08-14, the scientific consensus on Sermorelin is unknown. No claims extracted for this topic

This evidence brief synthesizes Synapse's enriched cardiology corpus; cite as synapsesocial.com/topics/peptide-sermorelin.

Deterministic synthesis from Synapse's enriched corpus — 54 words. No AI-generated novel content; every figure is sourced from the underlying paper, guideline, or trial record linked on this page.

Follow the latest Sermorelin research

Explore every Sermorelin paper on Synapse with AI-enriched clinical evidence, PICO analysis, and methodology classification.

Search Sermorelin papers